Pathologic Issues in the Treatment of Endoscopically Removed Malignant Colorectal Polyps

in Journal of the National Comprehensive Cancer Network

Endoscopically removed malignant colorectal polyps are early stage cancers for which treatment depends on histopathologic findings. For accurate pathologic evaluation, the polyps should be received in 1 piece because margins cannot be accurately assessed in fragmented polyps. Polyps with grade I or II cancer, no lymphovascular invasion, and a negative resection margin can be successfully treated with endoscopic polypectomy, whereas those with grade III cancer, lymphovascular invasion, or a positive or close margin require definitive surgical resection after endoscopic polypectomy. Potentially new significant parameters for patient management are depth of invasion and tumor budding. The pathology report must be clear and concise, indicating all relevant important parameters. The pathologist must differentiate invasive adenocarcinoma from intramucosal adenocarcinoma and pseudo-invasion.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Details

Correspondence: Harry S. Cooper, MD, Department of Pathology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. E-mail:


  • 1.

    RiddellRHPetrasREWilliamsGTSobinLH. Tumors of the intestines. In:Atlas of Tumor Pathology3rd Series. Washington, DC: Armed Forces Institute of Pathology; 2003.

  • 2.

    CooperHS. Intestinal neoplasms. In: Mills SE Carter D Greenson JK et al. eds.Sternberg's Diagnostic Surgical Pathology 4th ed.Philadelphia: Lippincott Williams & Wilkins2004.

  • 3.

    CooperHSDeppischLMGourleyWK. Endoscopically removed malignant colorectal polyps: clinical pathological correlations. Gastroenterology1995;108:16571665.

  • 4.

    VolkEEGoldblumJRPetrasRE. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology1995;109:18011807.

  • 5.

    LipperSKahnLBAckermanLV. The significance of microscopic invasive cancer in endoscopically removed polyps of the large bowel: clinical pathological study of 51 cases. Cancer1983;2:16911699.

  • 6.

    MorsonBCWhitewayJEJonesEA. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut1984;25:437444.

  • 7.

    CranleyJPPetrasRECareyWD. When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma?Gastroenterology1986;91:419427.

  • 8.

    BondJH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol2000;95:30533063.

  • 9.

    EngstromPFArnolettiJPBensonABIII. The NCCN colon cancer clinical practice guidelines in oncology version 12007. Available at: Accessed 11 September 2007.

  • 10.

    EngstromPFArnolettiJPBensonABIII. The NCCN rectal cancer clinical practice guidelines in oncology version 12007. Available at: Accessed 11 September 2007.

  • 11.

    HassanCAulloARisioM. Histological risk factors and clinical outcome in colorectal malignant polyp—a pooled data analysis. Dis Colon Rectum2005;48:15881596.

  • 12.

    SeitzUBohnackerSSeewaldS. Is endoscopic polypectomy adequate therapy for malignant colorectal adenoma? Presentation of 114 patients and review of the literature. Dis Colon Rectum2004;47:17891796.

  • 13.

    NetzerPBinckJHammerB. Significance of histological criteria for the management of patients with malignant colorectal polyps and polypectomy. Scand J Gastroenterol1997;323:915916.

  • 14.

    HackelsbergerAFruhmorgenPWeilerH. Endoscopic polypectomy and management of colorectal adenomas with invasive cancer. Endoscopy1995;27:153158.

  • 15.

    HaggittRCGlotzbachRESofferEEWrubleLD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology1985;89:328336.

  • 16.

    UenoHMochizukiHHashiguchiY. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology2004;127:385394.

  • 17.

    CoverlizzaSRisioMFerrariA. Colorectal adenomas containing invasive carcinoma. Pathological assessment of lymph node metastatic potential. Cancer1989;64:19371947.

  • 18.

    DukesCEBusseyHJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer1958;12:309320.

  • 19.

    NivatvongsSRojanajakulAReimanHM. The risk of lymph node metastasis in colorectal polyps with invasive adenocarcinoma. Dis Colon Rectum1991;34:323328.

  • 20.

    KyzerSBeginLRGordonPHMitmakerB. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy?Cancer1992;70:20442055.

  • 21.

    EgashraYYoshidaTHirataI. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod Pathol2004;17:503511.

  • 22.

    KitajimaKFujimoriTFugiS. Correlations between lymph node metastasis in depth of submucosal invasion and submucosal invasive colorectal carcinoma. J Gastroenterol2004;39:534543.

  • 23.

    MasakiTMatsuokaHSugiyamaM. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer2001;84:13171321.

  • 24.

    KanekoITanakaSOkaS. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis and submucosal colorectal cancer. Dis Colon Rectum2006;50:19.

Article Information


Google Scholar

Related Articles


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 8 8 3
PDF Downloads 4 4 4
EPUB Downloads 0 0 0